<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="https://blogs.mercola.com:443/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /><title>Insulin Prices Could Be Much Lower and Drug Makers Would Still Make Healthy Profits</title><link>https://blogs.mercola.com:443/sites/vitalvotes/archive/2018/09/30/insulin-prices-could-be-much-lower-and-drug-makers-would-still-make-healthy-profits.aspx</link><description>If you or someone you know is struggling to pay for your lifesaving insulin, a new study suggests that insulin costs could be rolled back considerably, and manufacturers would still make a respectable profit, Stat reports. In dollars and cents, this means</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Debug Build: 31106.3070)</generator></channel></rss>